Thoughts on COVID-19 and autoimmune diseases-Reference-Cited by-同舟云学术

Thoughts on COVID-19 and autoimmune diseases

Published:2020-04 Issue:1 Volume:7 Page:e000396
ISSN:2053-8790
Container-title:Lupus Science & Medicine
language:en
Short-container-title:Lupus Sci Med

Author:

Askanase Anca D^ORCID,Khalili Leila,Buyon Jill P

Abstract

Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.

Publisher

BMJ

Subject

Immunology,General Medicine

Reference24 articles.

1. World Health Organization . Coronavirus disease 2019 (COVID-19) situation report 48, 2020. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4

2. Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID-19) in the U.S, 2020. Available: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html#investigation

3. National Institute of Allergy and Infectious Diseases . Coronaviruses, 2020. Available: https://www.niaid.nih.gov/diseases-conditions/coronaviruses

4. Centers for Disease Control and Prevention . Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19), 2020. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

5. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period;Pathophysiology;2023-05-04

2. Therapeutic Targets in the Virological Mechanism and in the Hyperinflammatory Response of Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2);Applied Sciences;2023-03-31

3. DOENÇAS AUTOIMUNES RELACIONADOS A SÍNDROME DO PÓS-COVID-19: NOVOS DESDOBRAMENTOS DA PANDEMIA;Revista Contemporânea;2023-02-09

4. Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis;Expert Review of Respiratory Medicine;2022-09-08

5. The Impact of Telemedicine on Rheumatology Care;Frontiers in Medicine;2022-05-20